Veradigm Valuation
| MDRXDelisted Stock | USD 13.33 0.02 0.15% |
At this time, the company appears to be overvalued. Veradigm has a current Real Value of $10.93 per share. The regular price of the company is $13.33. Our model measures the value of Veradigm from inspecting the company fundamentals such as Return On Equity of 0.0893, shares outstanding of 109.26 M, and Operating Margin of 0.17 % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Veradigm's price fluctuation is very steady at this time. Calculation of the real value of Veradigm is based on 3 months time horizon. Increasing Veradigm's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Veradigm is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Veradigm Stock. However, Veradigm's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.33 | Real 10.93 | Hype 13.33 | Naive 13.05 |
The intrinsic value of Veradigm's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Veradigm's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Veradigm helps investors to forecast how Veradigm stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Veradigm more accurately as focusing exclusively on Veradigm's fundamentals will not take into account other important factors: Veradigm Total Value Analysis
Veradigm is now projected to have valuation of 395.97 M with market capitalization of 669.76 M, debt of 434.5 M, and cash on hands of 500.16 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Veradigm fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
395.97 M | 669.76 M | 434.5 M | 500.16 M |
Veradigm Investor Information
About 97.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.57. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Veradigm has Price/Earnings To Growth (PEG) ratio of 2.42. The entity last dividend was issued on the 7th of October 2008. Based on the analysis of Veradigm's profitability, liquidity, and operating efficiency, Veradigm is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.Veradigm Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Veradigm has an asset utilization ratio of 61.97 percent. This suggests that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that Veradigm is more efficient with each dollar of assets it utilizes for everyday operations.Veradigm Ownership Allocation
The majority of Veradigm outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Veradigm to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Veradigm. Please pay attention to any change in the institutional holdings of Veradigm as this could imply that something significant has changed or is about to change at the company.Veradigm Profitability Analysis
The company reported the previous year's revenue of 1.5 B. Net Income was 134.44 M with profit before overhead, payroll, taxes, and interest of 738.26 M.About Veradigm Valuation
Our relative valuation model uses a comparative analysis of Veradigm. We calculate exposure to Veradigm's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Veradigm's related companies.Allscripts Healthcare Solutions, Inc., together with its subsidiaries, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. Allscripts Healthcare Solutions, Inc. was founded in 1986 and is headquartered in Chicago, Illinois. Allscripts Hlthcare operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 8000 people.
Veradigm Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 138.7 M | |
| Quarterly Earnings Growth Y O Y | -0.018 | |
| Forward Price Earnings | 15.1745 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Other Consideration for investing in Veradigm Stock
If you are still planning to invest in Veradigm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Veradigm's history and understand the potential risks before investing.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |